113 related articles for article (PubMed ID: 19046710)
1. A patient with hyper-IgD syndrome responding to simvastatin treatment.
Attout H; Guez S; Ranaivo I; Jameerbaccus N; Series C
Eur J Intern Med; 2008 Dec; 19(8):e82-3. PubMed ID: 19046710
[No Abstract] [Full Text] [Related]
2. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Simon A; Drewe E; van der Meer JW; Powell RJ; Kelley RI; Stalenhoef AF; Drenth JP
Clin Pharmacol Ther; 2004 May; 75(5):476-83. PubMed ID: 15116060
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of simvastatin in plaque psoriasis: A pilot study.
Shirinsky IV; Shirinsky VS
J Am Acad Dermatol; 2007 Sep; 57(3):529-31. PubMed ID: 17707157
[No Abstract] [Full Text] [Related]
4. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.
Kotyla PJ; Sliwinska-Kotyla B; Kucharz EJ
J Rheumatol; 2006 Nov; 33(11):2361-3; author reply 2363. PubMed ID: 17086617
[No Abstract] [Full Text] [Related]
5. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
[No Abstract] [Full Text] [Related]
6. Statin helps heart failure patients without high cholesterol.
Levenson D
Rep Med Guidel Outcomes Res; 2003 Aug; 14(16):1, 5-6. PubMed ID: 12966938
[No Abstract] [Full Text] [Related]
7. Simvastatin may be a useful therapy in Dupuytren contracture.
Namazi H; Emami MJ
Med Hypotheses; 2006; 66(3):683-4. PubMed ID: 16343796
[No Abstract] [Full Text] [Related]
8. Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?
Mulders-Manders CM; Simon A
Semin Immunopathol; 2015 Jul; 37(4):371-6. PubMed ID: 25990874
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of xanthoma disseminatum with simvastatin.
Lee EH; Kang TW; Kim SC
J Dermatol; 2011 Oct; 38(10):1015-7. PubMed ID: 21592199
[No Abstract] [Full Text] [Related]
10. Cholesteryl ester storage disease in a young child presenting as isolated hepatomegaly treated with simvastatin.
Dalgiç B; Sari S; Gündüz M; Ezgü F; Tümer L; Hasanoğlu A; Akyol G
Turk J Pediatr; 2006; 48(2):148-51. PubMed ID: 16848116
[TBL] [Abstract][Full Text] [Related]
11. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
12. Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction.
Strandberg TE; Holme I; Faergeman O; Kastelein JJ; Lindahl C; Larsen ML; Olsson AG; Pedersen TR; Tikkanen MJ;
Am J Cardiol; 2009 May; 103(10):1381-5. PubMed ID: 19427432
[TBL] [Abstract][Full Text] [Related]
13. [SBU should investigate what is an evidence-based and cost-effective use of statins].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
[No Abstract] [Full Text] [Related]
14. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
15. Potential advantages of simvastatin as a novel anti-vitiligo arsenal.
Feily A; Baktash D; Mohebbipour A; Feily A
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1982-3. PubMed ID: 23877867
[No Abstract] [Full Text] [Related]
16. Pharmacopolitics, statin switching and therapeutic substitution: much ado about something.
Minhas R; Bogle RG; Patel KC; Moon JC
Int J Clin Pract; 2008 Mar; 62(3):354-5. PubMed ID: 18261067
[No Abstract] [Full Text] [Related]
17. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
18. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
19. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
Du Z; Chen J; Yan F; Xiao Y
Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
